11th February 2022 | Pharma Updates
Aurobindo Pharma eyes Rs. 1000 cr Indian pharma market
The drug company is targeting Rs. 1000 cr sales in the next three years from the date of the first launch and is ready to allocate capital if required.
Aptar Pharma launches New Manufacturing Facility
Aptar Pharma’s new manufacturing plant in Mumbai has molding capabilities to make innovative product solutions.
Esaote NA presents FDA-approved Magnifico Open MRI System
All-new open MRI system by Esaote North America is now available in USA.
Sense Biodetection partners with Una
Sense Biodetection signed a pact with Una Health to distribute Veros Covid testing kits in the UK.
Dolphin Vagal Stim gets a nod for covid treatment
Dolphin Vagal Stimulation device has gotten breakthrough approval from Health Canada as Canada’s first therapy for treating Covid infection.
ImpediMed introduces clinical trial for dialysis assistant
The human trial will enrol around 70 patients who will be under observation over four weeks and twelve dialysis.
Japan okays Pfizer Covid oral pills
Japan Health Ministry has granted fast-track approval to Pfizer Inc. ‘s Covid pill.
Novavax vaccine 80% effective among teens
The two-dose covid vaccine was found to be effective in 12-17 years kids.
Warburg Pincus buys Pharma Intelligence
Warburg Pincus bought Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa.
DePuy Synthes acquires CrossRoads Extremity Systems
Johnson & Johnson’s DePuy Synthes has purchased CrossRoads Extremity Systems.
